A professor emeritus from Emory University’s medical school was awarded $2.5 million last month in a dispute with a Florida company that entered a licensing agreement with him to market a product designed to detect and monitor harmful substances in the body.
Theodore Hersh, who also practiced at Emory Hospital before being forced into retirement by a degenerative eye disease, developed the Thione Antioxidant Complex and a home-test kit to detect free radicals in the body.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
